Bactana eyes industry partners for microbiome-focused licencing deal

摘要

US microbiome discovery start-up Bactana Animal Health intends to form a partnership or licence out its FPS-4 product platform, once it reaches the commercialization stage.The FPS-4 platform is based on a naturally-occurring collection of 'pioneer gut colonizers' selected from Faecalibacterium prausnitzii bacterium - a species initially identified by researchers at Cornell University for use in food-producing animals. Thecompany is developing this platform for both food animals and companion animals.